Efficacy of chemoradiotherapy on pain relief in patients with intrapelvic recurrence of rectal cancer

Japanese Journal of Clinical Oncology

Volumn 33, Issue 4, 2003, Pages 180-185

  Ito, Yoshinori ^a,b   Ohtsu, Atsushi ^a   Ishikura, Satoshi ^a   Boku, Narikazu ^a   Nihei, Keiji ^a   Ogino, Takashi ^a   Ikeda, Hiroshi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Chemoradiotherapy; Local recurrence; Pain relief; Radiotherapy; Rectal cancer

Indexed keywords

FLUOROURACIL; IRINOTECAN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FISTULA; HEMATURIA; HUMAN; ILEUS; LEUKOPENIA; MALE; METASTASIS POTENTIAL; RADIATION DOSE; RECTUM CANCER; RETROSPECTIVE STUDY; URETER OBSTRUCTION; ADENOCARCINOMA; CLINICAL TRIAL; METASTASIS; MULTIMODALITY CANCER THERAPY; PAIN; PATHOLOGY; PATHOPHYSIOLOGY; PELVIS TUMOR; RECTUM TUMOR; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; PAIN; PELVIC NEOPLASMS; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037794160     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg036     Document Type: Article

References (25)

1. Wanebo HJ, Koness RJ, Vezeridis MP, Cohen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer. Ann Surg 1994;220:586-95.
2. Pilipshen SJ, Heilweil M, Quan SH, Sternberg SS, Enker WE. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 1984;53:1354-62.
3. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
4. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181:335-46.
5. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564-72.
6. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
7. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997;336:980-7.
8. Maetani S, Nishikawa T, Iijima Y, Tobe T, Kotoura Y, Shikata J, et al. Extensive en bloc resection of regionally recurrent carcinoma of the rectum. Cancer 1992;69:2876-83.
9. Knol HP, Hanssens PE, Rutten HJ, Wiggers T. Effect of radiation therapy alone or in combination with surgery and/or chemotherapy on tumor and symptom control of recurrent rectal cancer. Strahlenther Onkol 1997;173: 43-9.
10. Wong R, Thomas G, Cummings B, Froud P, Shelley W, Withers R, et al. In search of a dose-response relationship with radiotherapy in the management of recurrent rectal carcinoma in the pelvis: A systematic review. Int J Radiat Oncol Biol Phys 1998;40:437-46.
11. Allum WH, Mack P, Priestman TJ, Fielding JW. Radiotherapy for pain relief in locally recurrent colorectal cancer. Ann R Coll Surg Engl 1987;69: 220-1.
12. Overgaard M, Overgaard J, Sell A. Dose-response relationship for radiation therapy of recurrent, residual and primarily inoperable colorectal cancer. Radiother Oncol 1984;1:217-25.
13. Wong CS, Cummings BJ, Brierley JD, Catton CN, McLean M, Catton P, et al. Treatment of locally recurrent rectal carcinoma - results and prognostic factors. Int J Radiat Oncol Biol Phys 1998;40:427-35.
14. Rominger CJ, Gunderson LL, Gelber RD, Conner N. Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16). Am J Clin Oncol 1985;8:118-27.
15. Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY Jr, Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2:865-7.
16. Danjoux CE, Gelber RD, Catton GE, Klaassen DJ. Combination chemoradiotherapy for residual, recurrent or inoperable carcinoma of the rectum: E.C.O.G study (EST 3276). Int J Radiat Oncol Biol Phys 1985;11:765-71.
17. Dunst J. Radiotherapy versus radiotherapy plus 5-FU in inoperable or recurrent rectal cancer. Strahlenther Onkol 1994;170:245-6.
18. Wong CS, Cummings BJ, Keane TJ, Dobrowsky W, O'Sullivan B, Catton CN. Combined radiation therapy, mitomycin C and 5-fluorouracil for locally recurrent rectal carcinoma: Results of a pilot study. Int J Radiat Oncol Biol Phys 1991;21:1291-6.
19. Leichman CG, Fleming TR, Muggia FM, Tangen CM, Ardalan B, Doroshow JH, et al. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: A Southwest Oncology Group Study. J Clin Oncol 1995;13:1303-11.
20. Ciatto S, Pacini P. Radiation therapy of recurrences of carcinoma of the rectum and sigmoid after surgery. Acta Radiol Oncol 1982;21:105-9.
21. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-14.
22. Becouarn Y, Ychou M, Ducreux M, Borel C, Bertheault-Cvitkovic F, Seitz JF, et al. Phase II study trial of oxaliplatin as first line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. J Clin Oncol 1998;16:2739-44.
23. Ohtsu A, Baba H, Sakata Y, Mitachi Y, Horikoshi N, Sugimachi K, et al. Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group. Br J Cancer 2000;83:141-5.
24. Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study. J Clin Oncol 2001;19:4097-106.
25. Suzuki K, Gunderson LL, Devine RM, Weaver AL, Dozois RR, Ilstrup DM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 1995;75:939-52.